Sugar-free mixers speed the absorption of alcohol into the bloodstream.» Read More
Think it's just tiny island nations that climate change will wash away? A UN report indicates a quarter of global GDP is at risk.
School hours and curfews have compressed trick-or-treating timeframes, forcing kids to strategize for maximum candy collection.
Mortgage rates bumped decidedly back over 4 percent last week, causing a drop in both mortgage applications to refinance and to purchase a home.
Years of record-breaking market highs have led investors to forget that accepting risk is inherent in any long-term investment strategy.
Although many consumers said they're concerned about their data, 56 percent will still shop at retailers that experienced a data breach.
As the Fed gets set to stop QE, Wall Street is already speculating it could crank up a new bond-buying program to take its place if the economy sours.
Americans say medical costs in retirement are their biggest financial concern, yet most have not factored those expenses into their plans.
CNBC counts down the 10 most unaffordable housing markets in the world — and U.S. homebuyers are in for a surprise.
For tech-savvy diners, snagging a Taco Bell burrito is now merely a few swipes away.
Amgen's CEO provided an answer to Dan Loeb's recent suggestion that the biotechnology company be split up. In short, he said, it doesn't make sense.
Coach is upbeat about its Stuart Vevers' collection, a key part of its turnaround plan, but investors may need more convincing as shares tumble.
Yahoo shares have surged 17 percent in the last 10 days to the highest level since 2000. Surprisingly, Alibaba's share price doesn't explain it all.
In recent appearances, Hillary Clinton has delivered progressive messages but Wall Street is not alarmed, Politico's Ben White says.
Many factors can decide the 2014 battle for Congress. But campaign money isn't likely to.
Ferrari is gearing up to start production on its invite-only supercar known as the Ferrari Sergio, and only six people will be able to buy one.
'Tis the season for charitable giving. Here's a look at popular crowdfunding campaigns that target problems ranging from Ebola to hunger.
The roller coaster ride for Sarepta continues, as it's likely to file for approval of its muscular dystrophy drug in mid-2015.
In a race to test antibodies that can unlock the mysteries of Ebola, Dr. Erica Saphire is crowdfunding her research to fast-forward efforts.
A great number of investments, many falling into the "alternative" category, simply don't deserve your attention—or dollars.
Discovery Capital has been battered by volatility, according to a report that disclosed losses of more than 20 percent in one of its main funds.